Evaluación de tratamiento hormonal de endometriosis en pacientes de 20-40 años en el hospital Teodoro Maldonado Carbo durante el año 2018-2019.

Abstract

Objectives: To evaluate the efficacy of hormonal treatment in endometriosis in patients aged 20-40 years at the Teodoro Maldonado Carbo hospital during the year 2018-2019. Methods: Comparative, observational, retrospective, cross-sectional and analytical study that evaluates patients diagnosed with endometriosis between 20 and 40 years old at the Teodoro Maldonado Carbo Hospital during the period from January 1 2018 to December 31, 2019. Results: Of the patients who presented clinical improvement, 38.14% were treated with Leuprolide, 15.46% with Desogestrel and 6.19% with Medroxyprogesterone. 73.69% obtained a decrease from 50.1% to 100%, 20% obtained a decrease from 25.1% to 50% and 6.32% from 1% to 25%. According to the percentage of decrease in Ca 125 according to the drug; 73.07% of the patients treated with Leuprolide obtained a decrease from 50.1 to 100%, 71.42% of those treated with Desogestrel decreased from 50.1 to 100% and of those treated with medroxyprogesterone 85.71% obtained a decrease from 75.1 to 100%. Conclusions: The use of leuprolide presents a better response in the treatment of patients diagnosed with endometriosis, compared to progestogens.